Logo image of CRNA.OL

CIRCIO HOLDING (CRNA.OL) Stock Price, Quote, News and Overview

OSL:CRNA - Euronext Oslo - NO0013033795 - Common Stock - Currency: NOK

0.641  0 (-0.62%)

CRNA.OL Quote, Performance and Key Statistics

CIRCIO HOLDING

OSL:CRNA (6/19/2025, 7:00:00 PM)

0.641

0 (-0.62%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High3.31
52 Week Low0.48
Market Cap60.73M
Shares94.74M
Float57.70M
Yearly DividendN/A
Dividend YieldN/A
PE0.23
Fwd PEN/A
Earnings (Next)08-28 2025-08-28
IPO06-16 2014-06-16


CRNA.OL short term performance overview.The bars show the price performance of CRNA.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10 15

CRNA.OL long term performance overview.The bars show the price performance of CRNA.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of CRNA.OL is 0.641 NOK. In the past month the price increased by 6.83%. In the past year, price decreased by -75.35%.

CIRCIO HOLDING / CRNA Daily stock chart

CRNA.OL Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1ABBV.MI ABBVIE INC 18.55 293.65B
4AB.DE ABBVIE INC 18.06 285.45B
AMG.DE AMGEN INC 13.93 135.53B
GIS.DE GILEAD SCIENCES INC 13.9 116.51B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 99.95B
1REGN.MI REGENERON PHARMACEUTICALS 11.89 49.56B
ARGX.BR ARGENX SE 101.09 28.77B
22UA.DE BIONTECH SE-ADR N/A 21.95B
IDP.DE BIOGEN INC 8.05 16.25B
1EXEL.MI EXELIXIS INC 18.73 9.81B
0QF.DE MODERNA INC N/A 8.56B
1MRNA.MI MODERNA INC N/A 8.44B

About CRNA.OL

Company Profile

CRNA logo image Circio Holding ASA is a biotechnology company, which engages in developing novel circular RNA and immunotherapy medicines. The company is headquartered in Lysaker, Akershus and currently employs 10 full-time employees. The company went IPO on 2014-06-16. The firm is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The firm offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.

Company Info

CIRCIO HOLDING

Vollsveien 19

Lysaker AKERSHUS NO

Employees: 9

CRNA Company Website

CRNA Investor Relations

Phone: 4721398810

CIRCIO HOLDING / CRNA.OL FAQ

What is the stock price of CIRCIO HOLDING today?

The current stock price of CRNA.OL is 0.641 NOK. The price decreased by -0.62% in the last trading session.


What is the ticker symbol for CIRCIO HOLDING stock?

The exchange symbol of CIRCIO HOLDING is CRNA and it is listed on the Euronext Oslo exchange.


On which exchange is CRNA.OL stock listed?

CRNA.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for CIRCIO HOLDING stock?

7 analysts have analysed CRNA.OL and the average price target is 3.06 NOK. This implies a price increase of 377.38% is expected in the next year compared to the current price of 0.641. Check the CIRCIO HOLDING stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is CIRCIO HOLDING worth?

CIRCIO HOLDING (CRNA.OL) has a market capitalization of 60.73M NOK. This makes CRNA.OL a Micro Cap stock.


How many employees does CIRCIO HOLDING have?

CIRCIO HOLDING (CRNA.OL) currently has 9 employees.


What are the support and resistance levels for CIRCIO HOLDING (CRNA.OL) stock?

CIRCIO HOLDING (CRNA.OL) has a support level at 0.64 and a resistance level at 0.65. Check the full technical report for a detailed analysis of CRNA.OL support and resistance levels.


Is CIRCIO HOLDING (CRNA.OL) expected to grow?

The Revenue of CIRCIO HOLDING (CRNA.OL) is expected to decline by -25.6% in the next year. Check the estimates tab for more information on the CRNA.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy CIRCIO HOLDING (CRNA.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CIRCIO HOLDING (CRNA.OL) stock pay dividends?

CRNA.OL does not pay a dividend.


When does CIRCIO HOLDING (CRNA.OL) report earnings?

CIRCIO HOLDING (CRNA.OL) will report earnings on 2025-08-28.


What is the Price/Earnings (PE) ratio of CIRCIO HOLDING (CRNA.OL)?

The PE ratio for CIRCIO HOLDING (CRNA.OL) is 0.23. This is based on the reported non-GAAP earnings per share of 2.79 and the current share price of 0.641 NOK. Check the full fundamental report for a full analysis of the valuation metrics for CRNA.OL.


CRNA.OL Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to CRNA.OL. When comparing the yearly performance of all stocks, CRNA.OL is a bad performer in the overall market: 93.4% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CRNA.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to CRNA.OL. Both the profitability and financial health of CRNA.OL have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CRNA.OL Financial Highlights

Over the last trailing twelve months CRNA.OL reported a non-GAAP Earnings per Share(EPS) of 2.79. The EPS increased by 116.74% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 263.5%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%107.52%
Sales Q2Q%-100%
EPS 1Y (TTM)116.74%
Revenue 1Y (TTM)-100%

CRNA.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 86% to CRNA.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of -183.35% and a revenue growth -25.6% for CRNA.OL


Ownership
Inst Owners0.16%
Ins Owners14.33%
Short Float %N/A
Short RatioN/A
Analysts
Analysts85.71
Price Target3.06 (377.38%)
EPS Next Y-183.35%
Revenue Next Year-25.6%